Bonesupport Holding

BONEX · Nasdaq Stockholm · SEK

222,60 krVariación respecto al cierre anterior: −1,50 %Variación absoluta: −3,40 kr

Cierre · 2 de octubre de 2026

Perfil de la empresa

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; and CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also provides CERAMENT Bead Tray, an adjunctive local delivery option for surgeons desiring targeted delivery to osseous defects and for dead space management. Bonesupport Holding AB (publ) was founded in 1999 and is headquartered in Lund, Sweden.

Descripción disponible en inglés.

Datos societarios

Sector
Salud
Industria
Medical Instruments & Supplies
País
Suecia
Sede
Scheelevägen 19, 223 70, Lund
Empleados
171
Cotización
BONEX · Nasdaq Stockholm
Divisa
SEK
ISIN
SE0009858152